Veriheal

FEBRUARY 21, 2023

Although respondents frequently have to choose “other conditions” to meet MMJ requirements, it’s an unfortunate reality for millions due to restrictive laws and policies, further skewing data towards more universally accepted health issues.

Access 98

Access Patients Chronic Pain Conditions 98

CannaTech

AUGUST 9, 2018

We are delighted to introduce you to some new friends set to make a big impact on the medical cannabis advocacy scene… the creators of a new documentary called Separating the Strains ; a deeply personal narrative that charts the reality of living with epilepsy, with and without cannabis medication as a treatment option.

Strains 69

Strains Epilepsy Advocacy Medicine 69

NORML

AUGUST 26, 2019

There are currently five “pharmaceutical processor” permit holders in Virginia, and they’re about to open for business. Now, in 2015 — like in many other states throughout the country — we saw some fresh faces in the marijuana policy conversation. As in, no to anyone who wasn’t an epilepsy patient.].

Marijuana 213

Marijuana Legalization Programs Oil 213

Cannabis Law Report

JUNE 26, 2019

In May 2019, Florida Commissioner of Agriculture Nikki Fried announced that a newly-created and appointed Medical Marijuana Advisory Committee of 18 doctors, lawyers, patients, industry leaders, and advocates will be implemented in order to “advance and modernize policies” to move Florida into the future of medical marijuana.

Marijuana 65

Marijuana Agriculture Research and Development Education 65

Cannabis Law Report

NOVEMBER 24, 2021

Chronic pain or pain were the conditions most frequently mentioned in articles about cannabis, followed by epilepsy, cancer or cancer pain, and nausea and chemotherapy. Refractory paediatric epilepsy. Conclusions. It was also used as a topical treatment for haemorrhoids, ear infection, and wounds (Aldrich 1997 ; Touw 1981 ).

Research and Development 52

Research and Development Medicine Access Media 52

The Cannigma

MAY 7, 2021

In Europe, Murphy explains, cannabis products are held to the same standards of accountability and repeatability as other pharmaceuticals. What do those more pharmaceutical standards mean for patients? MSO: Obviously, every country is different but within Europe and certain rainy islands close to it. SM: I think it’s stability.

Supply Chain 120

Supply Chain Patients Access Hemp 120